180 related articles for article (PubMed ID: 27392636)
1. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
2. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract][Full Text] [Related]
4. High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling.
Salawu A; Ul-Hassan A; Hammond D; Fernando M; Reed M; Sisley K
PLoS One; 2012; 7(11):e50415. PubMed ID: 23209738
[TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
6. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis.
Hosein AN; Song S; McCart Reed AE; Jayanthan J; Reid LE; Kutasovic JR; Cummings MC; Waddell N; Lakhani SR; Chenevix-Trench G; Simpson PT
Lab Invest; 2013 Jun; 93(6):701-10. PubMed ID: 23568031
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.
Lyons-Weiler M; Hagenkord J; Sciulli C; Dhir R; Monzon FA
Diagn Mol Pathol; 2008 Mar; 17(1):3-13. PubMed ID: 18303412
[TBL] [Abstract][Full Text] [Related]
9. Molecular inversion probes: a novel microarray technology and its application in cancer research.
Wang Y; Cottman M; Schiffman JD
Cancer Genet; 2012; 205(7-8):341-55. PubMed ID: 22867995
[TBL] [Abstract][Full Text] [Related]
10. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
11. High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues.
van Essen HF; Ylstra B
Methods Mol Biol; 2012; 838():329-41. PubMed ID: 22228020
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
14. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.
Grasso C; Butler T; Rhodes K; Quist M; Neff TL; Moore S; Tomlins SA; Reinig E; Beadling C; Andersen M; Corless CL
J Mol Diagn; 2015 Jan; 17(1):53-63. PubMed ID: 25468433
[TBL] [Abstract][Full Text] [Related]
15. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.
Kuglik P; Smetana J; Vallova V; Moukova L; Kasikova K; Cvanova M; Brozova L
Int J Clin Exp Pathol; 2014; 7(8):5071-82. PubMed ID: 25197380
[TBL] [Abstract][Full Text] [Related]
17. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
18. The utility and limitation of single nucleotide polymorphism analysis on whole genome amplified mesenchymal tumour DNA in formalin fixed tumour samples.
Liang CW; Lee YS; Marino-Enriquez A; Tsui K; Huang SH
Pathology; 2012 Jan; 44(1):33-41. PubMed ID: 22157688
[TBL] [Abstract][Full Text] [Related]
19. Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
Robbe P; Popitsch N; Knight SJL; Antoniou P; Becq J; He M; Kanapin A; Samsonova A; Vavoulis DV; Ross MT; Kingsbury Z; Cabes M; Ramos SDC; Page S; Dreau H; Ridout K; Jones LJ; Tuff-Lacey A; Henderson S; Mason J; Buffa FM; Verrill C; Maldonado-Perez D; Roxanis I; Collantes E; Browning L; Dhar S; Damato S; Davies S; Caulfield M; Bentley DR; Taylor JC; Turnbull C; Schuh A;
Genet Med; 2018 Oct; 20(10):1196-1205. PubMed ID: 29388947
[TBL] [Abstract][Full Text] [Related]
20. A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.
Conroy JM; Pabla S; Glenn ST; Seager RJ; Van Roey E; Gao S; Burgher B; Andreas J; Giamo V; Mallon M; Lee YH; DePietro P; Nesline M; Wang Y; Lenzo FL; Klein R; Zhang S
PLoS One; 2021; 16(12):e0260089. PubMed ID: 34855780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
